Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2007The Journal of ImmunologyOpen Access

Cutting Edge: The ST2 Ligand IL-33 Potently Activates and Drives Maturation of Human Mast Cells

View Full Paper
Ask AI
Bookmark
Share

Authors

ZAZoulfia AllakhverdiMcGill University Health CentreDSDirk E. SmithGlaxoSmithKline (United States)MCMichael R. ComeauRoswell Park Comprehensive Cancer Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Allakhverdi et al. (2007) studied this question.

synapsesocial.com/papers/69dafffa1e19c8ae08835fafhttps://doi.org/10.4049/jimmunol.179.4.2051
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1CD34+/Interleukin-5R α Messenger RNA+ Cells in the Bronchial Mucosa in Asthma: Potential Airway Eosinophil Progenitors1999 · 148 citations
  2. 2Selective Expression of a Stable Cell Surface Molecule on Type 2 but Not Type 1 Helper T Cells1998 · 511 citations
  3. 3Interleukin‐13 in asthma pathogenesis2004 · 685 citations
  4. 4IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor<i>in vivo</i>2006 · 967 citations
  5. 5The IL-1 Receptor-Related T1 Antigen Is Expressed on Immature and Mature Mast Cells and on Fetal Blood Mast Cell Progenitors1998 · 235 citations